---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-024450"
form_type: "8-K"
ticker: "CYPH"
cik: "0001509745"
company_name: "CYPHERPUNK TECHNOLOGIES INC."
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T15:33:02.965420+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Leap Therapeutics receives Nasdaq deficiency notice for low bid price; 180 days to cure

## Summary
- Closing bid price below $1.00 for 30 consecutive business days as of March 12, 2025.
- Company has until September 8, 2025 to regain compliance by closing at $1.00 for at least 10 consecutive days.
- Potential for additional 180-day compliance period if other listing standards met.
- Company reviewing options; no assurance of regaining compliance.
- Notice is a deficiency, not delisting; shares continue to trade on Nasdaq.

## SEC filing metadata
- accession: 0001104659-25-024450
- form_type: 8-K
- ticker: CYPH
- cik: 0001509745
- company_name: CYPHERPUNK TECHNOLOGIES INC.
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1509745/000110465925024450/0001104659-25-024450-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1509745/000110465925024450/tm259469d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-024450
- JSON: https://secwatch.observer/filing/0001104659-25-024450.json
- Plain text: https://secwatch.observer/filing/0001104659-25-024450.txt

## Key facts
- Listing & Compliance Notices
  CYPHERPUNK TECHNOLOGIES INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: f The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). The Closing Bid Price Deficiency Letter is a notice of deficiency, not delisting, and does not currently affect the listing or trading of the Company’s shares of common stock on The Nasdaq Capital Market. The Company has 180 days, or until September 8, 2025, to regain
  evidence_url: https://www.sec.gov/Archives/edgar/data/1509745/000110465925024450/0001104659-25-024450-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.